1,9-Pyrazoloanthrone
1,9-Pyrazoloanthrone ≥98% (by TLC)
Supplier: Enzo Life Sciences
Potent, cell permeable, selective, and reversible inhibitor of c-Jun N-terminal kinase (JNK) (IC50=40nM for JNK-1 and JNK-2 and 90nM for JNK-3). The inhibition is competitive with respect to ATP. Exhibits over 300-fold greater selectivity for JNK as compared to ERK1 and p38. Inhibits the phosphorylation of c-Jun and blocks the expression of IL-2, IFN-γ, TNF-α, and COX-2. Blocks IL-1-induced accumulation of phospho-Jun, induction of c-Jun transcription and anti CD3-induced apoptosis of CD4+ CD8+ thymocytes.
Expand 2 Items
1,9-Pyrazoloanthrone
Supplier: Abcam
Potent and selective JNK1, -2, and -3 inhibitor (IC₅₀ = 0,11 μM). SP600125 is a reversible ATP-competitive inhibitor with 20-fold selectivity over a range of kinases. It dose-dependently inhibits the phosphorylation of c-Jun and the expression of infla mMatory genes COX-2, IL-2, IFNγ and TNFα. Neuroprotective in vivo.
Expand 2 Items
1,9-Pyrazoloanthrone ≥99%
Supplier: Apollo Scientific
Novel, potent and selective JNK-1,-2, and -3 inhibitor (Ki = 0.19 uM). SP600125 is an ATP-competitive reversible inhibitor with >20-fold selectivity vs. a range of kinases and enzymes tested. Proc. Natl. Acad. Sci. USA 98: 13681-13686 (2001).
Expand 2 Items
1,9-Pyrazoloanthrone 99%
Supplier: Thermo Fisher Scientific
1,9-Pyrazoloanthrone 99%